Net sales rose 23% and recurring revenues 28% year-over-year in Q1 2025, with EBITA flat and margins down. Acquisition of Intergrip expanded the portfolio, while cash flow from operations improved.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.